New anti-smoking weapon
October 26, 2012
QUITTING smoking is just a few
sprays away thanks to the launch of
Nicorette’s new QuickMist Mouth
Spray.
The new nicotine replacement
therapy is said to start to relieve
cravings in just 60 seconds, providing
relief 2.7 times quicker than a
nicotine 4mg lozenge (median time to
50% cravings reduction 3.4mins for
QuickMist vs. 9.2 mins for lozenge).
In addition, the QuickMist Mouth
Spray provides maximum relief at
10 minutes compared to nicotine
4mg lozenge at 25 minutes (mean
craving VAS score at the time of
maximum relief 29.2mm for
QuickMist vs. 26.3mm for lozenge).
According to Nicorette, the
maximum concentration of nicotine
was observed no later than 12.5
minutes for QuickMist and no
earlier than 45 minutes for nicotine
4mg lozenge.
A placebo-controlled, double blind,
multicenter study with a year-long
follow up also found that
the QuickMist demonstrated
proven efficacy for long-term
abstinence, being 2.5 times
more effective at helping
smokers quit compared
with placebo at 52 weeks.
“Most people who go
without smoking experience
urges to smoke,” said Dr
Hayden McRobbie, Reader
in Public Health
Interventions at the
Wolfson Institute of
Preventive Medicine,
Queen Mary University of London.
“At times these can be
overwhelming and leads to relapse.
“The faster a product can act to
reduce urges to smoke the better
they will be in helping many people
to stay away from cigarettes.
“This mouth spray has been
shown to alleviate urges to smoke
quickly, and increase the chances of
quitting smoking for good and it
will provide another opportunity
for smokers to give quitting a go,”
McRobbie added.
The recommended dosage of
QuickMist is one to two sprays
every 30 minutes to one hour, and
no more than four sprays per hour
or 64 sprays per day, into the side
of the cheek or under the tongue.
QuickMist can also be used in
combination with Nicorette Patch if
breakthrough craving is experienced
or there is difficulty in controlling
cravings for cigarettes.
Pictured below at QuickMist’s
launch this week is Declan Rooney,
Associate Professor Renee Bittoun,
and Dr Hayden McRobbie.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Oct 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Oct 12
